Historically, European governments, driven by global treaties like the 1961 Single Convention on Narcotic Drugs, categorised cannabis as a dangerous drug, to be outlawed and…
Golan has by turns been described as a fashion entrepreneur, travel and lifestyle influencer, public speaker, TV host, and actress. Yet, to put one specific…
Investment in the metaverse hit $120bn in 2022 and it shows no sign of slowing. It's been described as a platform for gamers, a virtual…
A change in attitude - I read that Japanese people tend to see doctors’ words as indisputable authority; and if doctors disapprove of cannabis, there is…
Regulations changes - This week the QLD government removed the state approval process required for patients to access medical cannabis. Now doctors will only require Federal…
The importance of standardization - Authorities across Europe have listed 114 products containing CBD in the European Union’s food-safety alert system since the start of last…
Export of cannabis - Canadian businesses exported more dried medical cannabis than ever last year, but that growth is expected to be challenged when the country’s…
Cannabis vaporization and pain - A study led by a team of Israeli scientists, published earlier recently in the European Journal of Pain, found precise doses…
The wonders of psychedelic compounds - A beautiful excerpt from Franz X. Vollenweider, recent years have seen a burgeoning scientific interest in the neurobiology of altered states…
MDMA for PTSD - MDMA, the active ingredient in the party drug ecstasy, is being touted as a game-changing treatment for post-traumatic stress disorder. It is being…
Cannabis in Germany - A great article by my good friend Alfredo Pascual (Link) - Germany imported 1,032 kilograms (2,275 pounds) of medical cannabis flower for pharmacy…
The marvel of the cannabis plant is endless - here is an excerpt I came across this week speaking about the cannabis Sativa plant. The plant…
CBD and anxiety - It is very likely that CBD will eventually become a treatment for anxiety (amongst other things). A study conducted by researchers at…
A note on psychedelics - Before they were banned about a half-century ago, psychedelic drugs like LSD and psilocybin showed promise for treating conditions including alcoholism…
Based on limited time, I’ve postponed top-level insights this week. I do know to acknowledge the great work the ACI is doing in the U.K.…
Differentiated delivery formats are still an area of uncharted territory amongst cannabis companies. There are several products in the market with minimal pharmacokinetic data to…
This week I read that overall U.S. sale of legalised cannabis was expected to reach $13.6 billion throughout 2019, up 32% from 2018’s total of…
Once again, the WHO is expecting to delay the vote affecting the scheduling of THC and CBD. At a time where CBD across the EU…
The coronavirus outbreak in China likely will benefit American hemp companies that compete with Chinese suppliers on the global and domestic markets. And this newest…
Europe offers growth opportunities for the next wave of cannabis organisations. The UK, Germany, Italy and the Netherlands already have legal systems in place for…
Brazil and New Zealand share common fates as the two countries open up patients' ability to access medical cannabis. Both countries emphasise GMP only products,…
3,682 medicinal cannabis prescriptions were approved via SAS Category B in December 2019. Prescriptions throughout 2019, increased month on month excluding November which dropped by…
The growing concern over calories and hangovers is driving more millennials to replace alcohol with cannabis in their social life. A recent study by Future…
Cannabis production may be too risky and restrictive for new cultivation companies. High input costs, unstable genetics, and a steep learning curve lead to non-viable…